Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 413 News Items found In the Lab Scientists Home in on Treatment Advance for Chemotherapy-Resistant Small Cell Lung Cancer Monday, February 13, 2017 An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack. In the Clinic Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds Wednesday, November 28, 2018 The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer. Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations Monday, November 2, 2026 Learn how MSK doctors are treating lung cancer in clinical trials with daraxonrasib, which targets RAS mutations in tumors. In the Clinic Personalized Medicine 2.0: MSK Leads the Way in the Study of Drug Resistance in Lung Cancer Thursday, November 29, 2018 Overcoming resistance to drug treatment for lung cancer is a critical challenge. In the Clinic MSK’s New Fiona and Stanley Druckenmiller Center for Lung Cancer Research Takes on Biggest Cancer Killer Friday, January 8, 2016 The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation. Roundup Year in Review: Five Important Clinical Advances in Cancer in 2020 Monday, December 21, 2020 Read about some of the most important clinical advances made at MSK in 2020. Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why It’s So Aggressive Thursday, October 14, 2021 Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering. Feature How Four Decades of Research Led to an Important Advance in Lung Cancer Monday, May 24, 2021 Read how a clinical trial is changing the outlook for some people with lung cancer. MSK Scientists Reveal Biology of Shape-Shifting Lung Cancer Wednesday, July 7, 2021 Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes. Targeted Therapy Selpercatinib Approved for Lung and Thyroid Cancers With RET Gene Mutations or Fusions Tuesday, May 26, 2020 The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to selpercatinib (Retevmo™) for lung and thyroid cancers with RET (REarranged during Transfection) gene mutations or fusions. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »